INJECTAPLAS LIMITED

Company Registration Number:
04628580 (England and Wales)

Unaudited abridged accounts for the year ended 31 December 2024

Period of accounts

Start date: 01 January 2024

End date: 31 December 2024

INJECTAPLAS LIMITED

Contents of the Financial Statements

for the Period Ended 31 December 2024

Balance sheet
Notes

INJECTAPLAS LIMITED

Balance sheet

As at 31 December 2024


Notes
2024
2023


£
£
Fixed assets
Tangible assets: 3 103,612 90,417
Total fixed assets: 103,612 90,417
Current assets
Stocks: 105,960 47,480
Debtors:   170,607 163,852
Cash at bank and in hand: 148,253 301,004
Total current assets: 424,820 512,336
Creditors: amounts falling due within one year: 4 (198,346) (291,159)
Net current assets (liabilities): 226,474 221,177
Total assets less current liabilities: 330,086 311,594
Creditors: amounts falling due after more than one year:     (18,334)
Provision for liabilities: (25,904) (22,605)
Total net assets (liabilities): 304,182 270,655
Capital and reserves
Called up share capital: 25,000 25,000
Profit and loss account: 279,182 245,655
Shareholders funds: 304,182 270,655

The notes form part of these financial statements

INJECTAPLAS LIMITED

Balance sheet statements

For the year ending 31 December 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 26 September 2025
and signed on behalf of the board by:

Name: C W D WHELAN
Status: Director

The notes form part of these financial statements

INJECTAPLAS LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2024

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

INJECTAPLAS LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2024

2. Employees

2024 2023
Average number of employees during the period 7 9

INJECTAPLAS LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2024

3. Tangible Assets

Total
Cost £
At 01 January 2024 148,854
Additions 61,016
Disposals (81,001)
At 31 December 2024 128,869
Depreciation
At 01 January 2024 58,437
Charge for year 11,473
On disposals (44,653)
At 31 December 2024 25,257
Net book value
At 31 December 2024 103,612
At 31 December 2023 90,417

INJECTAPLAS LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2024

4. Creditors: amounts falling due within one year note

TRADE CREDITORS £118,369 TAXATION £39,691 ACCRUALS £13,000 HIRE PURCHASE £15,461 OTHERS £11,825